• RAPS AnnouncementsRAPS Announcements
    RAPS' LatestRAPS' Latest

    Regulatory professionals’ average compensation continues to increase, according to RAPS’ 2020 compensation survey

    RAPS today released the results of its biennial global survey of regulatory professionals working in the healthcare products sector. RAPS’ 2020 Global Compensation & Scope of Practice Report for the Regulatory Profession provides a detailed look at how much regulatory professionals earn, who they are, and what their work entails. The comprehensive survey collected salary and demographic data for nearly 2,000 respondents from around the world. The average total compens...
  • RAPS' LatestRAPS' Latest

    RAPS Releases Results of Compensation Survey of Regulatory Professionals

    RAPS today released the results of its comprehensive global survey of healthcare product regulatory professionals, offering a detailed look at how much they earn, which products they work on, what their work entails, and how their roles within their organizations have evolved. RAPS’ 2018 Global Compensation & Scope of Practice Report for the Regulatory Profession aggregates salary data for more than 2,300 respondents from 64 countries and breaks down median and averag...
  • RAPS' LatestRAPS' Latest

    RAPS' Scope of Practice Survey Shows Regulatory Pros Play Increasingly Strategic Role Compensation Up

    RAPS today released the results of its biennial survey of healthcare product regulatory professionals around the world. The survey asked respondents about their daily work, education and professional backgrounds, and compensation. RAPS has compiled and published key survey results and analysis in its 2016 Scope of Practice & Compensation Report for the Regulatory Profession , which can be downloaded at www.RAPS.org/sop . Among the most significant findings, r...
  • RAPS' LatestRAPS' Latest

    RAPS Launches Global Survey of Regulatory Professionals' Work and Compensation

    RAPS has just launched its biennial global survey of regulatory professionals who work with healthcare and related products. RAPS’ Scope of Practice & Compensation Survey of the Regulatory Profession , conducted every two years, is the largest and most comprehensive survey of professionals in this important field, vital to ensuring healthcare products are safe and effective. Respondents work in the pharmaceutical, biotechnology and medical device industries, governme...
  • RAPS' LatestRAPS' Latest

    RAPS Wants to Know How to Better Help You Survey Deadline: 27 March

    • 24 March 2015
    RAPS has launched a new survey as part of its effort to improve the RAPS.org website and make it the best source of information and resources for regulatory professionals around the world. You have until Friday, 27 March to take this brief survey, which is open to everyone in the RAPS community—RAPS members and nonmembers alike. RAPS’ ultimate goal is to provide more valuable content online and make RAPS.org easier to use, so the questions focus on the needs and pr...
  • Regulatory NewsRegulatory News

    Too Fast, or Too Slow? Public Disagrees Over Pace of FDA's New Drug Approvals

    According to a new survey, the US Food and Drug Administration (FDA) is in a lose-lose situation when it comes to regulating healthcare products. FDA's Lose-Lose Proposition The poll, sponsored by research advocacy group Research!America and conducted with help from Zogby Analytics, polled approximately 1,000 adults about their views on America's role in public health research and development. The research indicates, for example, that Americans are broadly in favor of ...
  • Regulatory NewsRegulatory News

    With PDUFA VI Negotiation Process Fast Approaching, BIO Takes Critical Look at Regulations

    The Biotechnology Industry Organization (BIO), a trade group which represents biopharmaceutical companies, is launching a new tracking tool meant to assess how companies interact with the US Food and Drug Administration (FDA) in the hopes of improving the drug development process, it announced today. The survey is specifically meant to inform negotiations over the next iteration of the Prescription Drug User Fee Act (PDUFA), which was last authorized in 2012 and it...
  • Feature ArticlesFeature Articles

    Proving a Professional’s Regulatory Worth During Salary Negotiations

    Even if a person does not get what is deserved in life, a regulatory professional often has a better chance of getting what is deserved on the job if he or she can negotiate salary effectively. To evaluate worth to an employer, the regulatory professional must know him- or herself, the business ecosystem and his or her ability to deliver desired professional qualifications. Many employees do not negotiate their salaries. The reasons people shun negotiations include: fe...
  • Regulatory NewsRegulatory News

    CDRH Sees Customer Satisfaction as a Driver of Innovation, Good Regulation

    The Center for Devices and Radiological Health (CDRH), the US Food and Drug Administration's (FDA) device regulatory branch, has a question for industry: How have we helped you lately? Background It's a bit of an odd question without context. In February 2014, CDRH launched a new document, CDRH 2014-2015 Strategic Priorities , in which it said the device center would be focusing on three things in 2014: strengthening clinical trials, balancing pre- and post-mark...
  • RAPS' LatestRAPS' Latest

    Survey of Regulatory Pros Draws Increasingly Global Response

    RAPS' biennial research survey of the regulatory profession, launched at the end of January and continuing through Monday, 31 March, has garnered well over 2,000 responses to date, with 29% from outside the US. The Global Scope of Practice & Compensation Survey has been conducted by RAPS for nearly 25 years, and it continues to be the largest, most comprehensive study of the healthcare products regulatory profession. Increasingly, survey responses are coming from p...
  • RAPS' LatestRAPS' Latest

    RAPS Launches Global Survey of Regulatory Professionals

    • 28 January 2014
    RAPS today launched the 2014 Scope of Practice &Compensation Survey of the Regulatory Profession , a survey of professionals around the world-both RAPS members and nonmembers-who are involved with the regulatory process for healthcare products. The survey asks regulatory professionals working in the pharmaceutical, biotechnology and medical device industries; regulatory agencies; academia, consultancies and other settings about their jobs, backgrounds and compensati...
  • Public Warms to FDA in Recent Gallup Poll

    How good is the US Food and Drug Administration (FDA) at doing its job? While the question is a source of frequent debate among members of pharmaceutical and medical device industries, a new Gallup poll shows that FDA's approval numbers among the general public have improved significantly in recent years, putting it ahead of even some of the US' most beloved agencies. The poll found that 45% of respondents thought that FDA was doing either an "excellent" or "good" job,...